ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE

Clinical trials for ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE explained in plain language.

Never miss a new study

Get alerted when new ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE trials appear

Sign up with your email to follow new studies for ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill aims to stop second strokes without raising bleeding risk

Prevention Completed

This large, international study tested whether a new oral blood thinner called asundexian could safely prevent another stroke in people who had just experienced a clot-based stroke or a high-risk mini-stroke (TIA). Over 12,000 participants took either asundexian or a placebo pill…

Matched conditions: ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE

Phase: PHASE3 • Sponsor: Bayer • Aim: Prevention

Last updated Mar 25, 2026 14:08 UTC

ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE

Get alerted when new ACUTE NON-CARDIOEMBOLIC ISCHEMIC STROKE trials appear

New pill aims to stop second strokes without raising bleeding risk